1) Agarwal RC, Singh SP, Saran RK, et al. Clinical
trial of gugulipid--a new hypolipidemic agent of plant origin in
primary hyperlipidemia. Indian J Med Res 1986;84:626-634.
2) Amma MK, Malhotra N, Suri RK, et al. Effect of
oleoresin of gum guggul (Commiphora mukul) on the reproductive
organs of female rat. Indian J Exp Biol 1978;16(9):1021-1023.
3) Antonio J, Colker CM, Torina GC, et al. Effects
of a standardized guggulsterone phosphate supplement on body
composition in overweight adults: A pilot study. Curr Ther Res
1999;60:220-227.
4) Arora RB, Kapoor V, Gupta SK, et al. Isolation
of a crystalline steroidal compound from Commiphora mukul & its
anti-inflammatory activity. Indian J Exp Biol 1971;9(3):403-404.
5) Arora RB, Taneja V, Sharma RC, et al.
Anti-inflammatory studies on a crystalline steroid isolated from
Commiphora mukul. Indian J Med Res 1972;60(6):929-931.
6) Baldwa VS, Sharma RC, Ranka PC, et al. Effect
of Commiphora mukul (guggul) on fibrinolytic activity and platelet
aggregation in coronary artery disease. Rajas Med J
1980;19(2):84-86.
7) Beg M, Singhal KC, Afzaal S. A study of effect
of guggulsterone on hyperlipidemia of secondary glomerulopathy.
Indian J Physiol Pharmacol 1996;40(3):237-240.
8) Bhatt AD, Dalal DG, Shah SJ, et al. Conceptual
and methodologic challenges of assessing the short-term efficacy of
Guggulu in obesity: data emergent from a naturalistic clinical
trial. J Postgrad Med 1995;41(1):5-7.
9) Bordia A, Chuttani SK. Effect of gum guggulu on
fibrinolysis and platelet adhesiveness in coronary heart disease.
Indian J Med Res 1979;70:992-996.
10) Brown D, Austin S. Hyperlipidemia and
Prevention of Coronary Artery Disease. Seattle, WA: NPRC, 1997,
4-6.
11) Cui J, Huang L, Zhao A, et al. Guggulsterone
is a farnesoid X receptor antagonist in coactivator association
assays but acts to enhance transcription of bile salt export pump. J
Biol Chem 2003;278(12):10214-10220.
12) Dalvi SS, Nayak VK, Pohujani SM, et al. Effect
of gugulipid on bioavailability of diltiazem and propranolol. J
Assoc Physicians India 1994;42(6):454-455.
13) Das Gupta RD. Gugulipid: pro-lipaemic effect.
J Assoc Physicians India 1990;38(8):598.
14) Das Gupta R. Gugulipid: pro-lipaemic effect. J
Assoc Physicians India 1990;38(12):346.
15) Dogra J, Aneja N, Saxena VN. Oral gugulipid in
acne vulgaris management. Ind J Dermatol Venereol Leprol
1990;56(1):381-383.
16) Duwiejua M, Zeitlin IJ, Waterman PG, et al.
Anti-inflammatory activity of resins from some species of the plant
family Burseraceae. Planta Med 1993;59(1):12-16.
17) Gaur SP, Garg RK, Kar AM, et al. Gugulipid, a
new hypolipidaemic agent, in patients of acute ischaemic stroke:
effect on clinical outcome, platelet function and serum lipids. Asia
Pacif J Pharm 1997;12:65-69.
18) Ghorai M, Mandal SC, Pal M, et al. A
comparative study on hypocholesterolaemic effect of allicin, whole
germinated seeds of bengal gram and guggulipid of gum gugglu.
Phytother Res 2000;14(3):200-202.
19) Gopal K, Saran RK, Nityanand S, et al.
Clinical trial of ethyl acetate extract of gum gugulu (gugulipid) in
primary hyperlipidemia. J Assoc Physicians India 1986;34(4):249-251.
20) Gujral ML, Sareen K, Reddy GS, et al.
Endocrinological studies on the oleo resin of gum guggul. Indian J
Med Sci 1962;16:847-851.
21) Jadad AR, Moore RA, Carroll D, et al.
Assessing the quality of reports of randomized clinical trials: is
blinding necessary? Control Clin Trials 1996;17(1):1-12.
22) Jain JP. Clinical assessment of the value of
oleo-resin of Commiphora mukul (Guggul) in obesity and
hyperlipidemia. ICMR Bull 1980;10:83-84.
23) Kesava RG, Dhar SC. Effect of a new
non-steroidal anti-inflammatory agent on lysosomal stability in
adjuvant induced arthritis. Ital J Biochem 1987;36(4):205-217.
24) Kesava RG, Dhar SC, Singh GB. Urinary
excretion of connective tissue metabolites under the influence of a
new non-steroidal anti-inflammatory agent in adjuvant induced
arthritis. Agents Actions 1987;22(1-2):99-105.
25) Kishore P, Devi Das KV, Banarjee S. Clinical
studies on the treatment of Amavata-Rheumatoid arthritis with
Sunthi-Guggulu. J Res Ayur Siddha 1982;3(3-4):133-146.
26) Kotiyal JP, Bisht DB, Singh DS. Double blind
cross-over trial of gum guggulu (Commiphora mukul) Fraction A in
hypercholesterolemia. J Res Indian Med Yoga Hom 1979;14(2):11-16.
27) Kotiyal JP, Singh DS, Bisht DB. Gum guggulu (Commiphora
mukul) fraction 'A' in obesity -- a double-blind clinical trial. J
Res Ayur and Siddha 1985;6(1,3,4):20-35.
28) Kuppurajan K, Rajagopalan SS, Koteswara Rao T,
et al. Effect of guggulu (Commiphora mukul-Engl) on serum lipids in
obese subjects. J Res Indian Med 1973;8(4):1-8.
29) Kuppurajan K, Rajagopalan SS, Rao TK, et al.
Effect of guggulu (Commiphora mukul--Engl.) on serum lipids in
obese, hypercholesterolemic and hyperlipemic cases. J Assoc
Physicians India 1978;26(5):367-373.
30) Mahesh S, Pandit M, Hakala C. A study of
Shuddha Guggulu on rheumatoid arthritis. Rheumatism
1981;16(2):54-67.
31) Majumdar KA. A clinical study of R-Arthritis
with A-Compound - a herbal formulation. Rheumatism 1984;19(3):66-74.
32) Majumdar KA. Role of gum guggulu with gold in
rheumatic and other allied disorders. Rheumatism 1984;20(1):9-15.
33) Malhotra SC, Ahuja MM. Comparative
hypolipidaemic effectiveness of gum guggulu (Commiphora mukul)
fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su.
Indian J Med Res 1971;59(10):1621-1632.
34) Malhotra SC, Ahuja MM, Sundaram KR. Long term
clinical studies on the hypolipidaemic effect of Commiphora mukul (Guggulu)
and clofibrate. Indian J Med Res 1977;65(3):390-395.
35) Mester L, Mester M, Nityanand S. Inhibition of
platelet aggregation by "guggulu" steroids. Planta Med
1979;37(4):367-369.
36) Nityanand S, Srivastava JS, Asthana OP.
Clinical trials with gugulipid. A new hypolipidaemic agent. J Assoc
Physicians India 1989;37(5):323-328.
37)Nityanand S, Kapoor NK. Hypocholesterolemic
effect of Commiphora mukul resin (Guggal). Indian J Exp
Biol 1971;9:367-77.
38)Satyavati GV. Gum guggul (Commiphora mukul)-The
success of an ancient insight leading to a modern discovery.
Indian J Med 1988;87:327-35.
39) Sharma K, Puri AS, Sharma R, et al. Effect of
gum guggul on serum lipids in obese subjects. J Res Indian Med Yoga
Hom 1976;11(2):132.
40) Sharma JN, Sharma JN. Comparison of the
anti-inflammatory activity of Commiphora mukul (an indigenous drug)
with those of phenylbutazone and ibuprofen in experimental arthritis
induced by mycobacterial adjuvant. Arzneimittelforschung
1977;27(7):1455-1457.
41) Sidhu LS, Sharma K, Puri AS, et al. Effect of
gum guggul on body weight and subcutaneous tissue folds. J Res
Indian Med Yoga Hom 1976;11(2):16-22.
42) Singh RP, Singh R, Ram P, et al. Use of
Pushkar-Guggul, an indigenous antiischemic combination, in the
management of ischemic heart disease. Int J Pharmacog
1993;31(2):147-160.
43) Singh BB, Mishra L, Aquilina N, et al.
Usefulness of guggul (Commiphora mukul) for osteoarthritis of the
knee: An experimental case study. Altern Ther Health Med
2001;7(2):120, 112-114.
44) Singh GB, Atal CK. Pharmacology of an extract
of salai guggal ex-Boswellia serrata, a new non-steroidal
anti-inflammatory agent. Agents Actions 1986;18(3-4):407-412.
45) Singh RB, Niaz MA, Ghosh S. Hypolipidemic and
antioxidant effects of Commiphora mukul as an adjunct to dietary
therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther
1994;8(4):659-664.
46)Singh K, Chander R, Kapoor NK. Guggulsterone, a
potent hypolipidaemic, prevents oxidation of low density
lipoprotein. Phytother Res 1997;11:291-4.
47) Sosa S, Tubaro R, Della Loggia R, et al.
Anti-inflammatory activity of Commiphora mukul extracts. Pharmacol
Res 1993;27(suppl 1):89-90.
48) Szapary PO, Wolfe ML, Bloedon LT, et al.
Guggulipid for the treatment of hypercholesterolemia: a randomized
controlled trial. JAMA 2003;290(6):765-772.
49) Thappa DM, Dogra J. Nodulocystic acne: oral
gugulipid versus tetracycline. J Dermatol 1994;21(10):729-731.
50) Tripathi SN, Upadhyay BN. A clinical trial of
Commiphora mukul in the patients of ischaemic heart disease. J Mol
and Cell Cardiol 1978;10(suppl 1):124.
51) Tripathi SN, Gupta M, Sen SP, et al. Effect of
a keto-steroid of Commifora mukul L. on hypercholesterolemia &
hyperlipidemia induced by neomercazole & cholesterol mixture in
chicks. Indian J Exp Biol 1975;13(1):15-18.
52) Tripathi YB, Malhotra OP, Tripathi SN. Thyroid
stimulating action of Z-guggulsterone obtained from Commiphora mukul.
Planta Med 1984;(1):78-80.
53) Tripathi YB, Tripathi P, Malhotra OP, et al.
Thyroid stimulatory action of (Z)-guggulsterone: mechanism of
action. Planta Med 1988;54(4):271-277.
54) Upadhyaya BN, Tripathi SN, Dwivedi LD.
Hypocholesterolemic and hypolipidemic action of gum guggulu in
patients of coronary heart disease. J Res Indian Med Yoga Hom
1976;11(2):1-8.
55) Urizar NL, Liverman AB, Dodds DT et al. A
natural product that lowers cholesterol as an antagonist ligand for
the FXR. Science (Science Express Reports) 2002 (May 3).
56) Verma SK, Bordia A. Effect of Commiphora mukul
(gum guggulu) in patients of hyperlipidemia with special reference
to HDL-cholesterol. Indian J Med Res 1988;87:356-360.
57) Wu J, Xia C, Meier J, et al. The hypolipidemic
natural product guggulsterone acts as an antagonist of the bile acid
receptor. Mol Endocrinol 2002;16(7):1590-1597.
